User profiles for Viviane Lima

Viviane Dias Lima

BC Centre for Excellence in HIV/AIDS & University of British Columbia
Verified email at bccfe.ca
Cited by 14130

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based …

JSG Montaner, VD Lima, R Barrios, B Yip, E Wood… - The Lancet, 2010 - thelancet.com
Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …

[HTML][HTML] Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada

…, TL Patterson, JSG Montaner, RS Hogg, VD Lima - PloS one, 2012 - journals.plos.org
Objective To establish the reliability and validity of a shortened (10-item) depression scale
used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia…

[PDF][PDF] Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals

…, J Grebely, M Hellard, SJ Hutchinson, VD Lima… - …, 2013 - Wiley Online Library
Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs
(PWID) cannot be achieved by harm reduction interventions such as needle exchange and …

[HTML][HTML] Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as …

JSG Montaner, VD Lima, PR Harrigan, L Lourenço… - PloS one, 2014 - journals.plos.org
Background There has been renewed call for the global expansion of highly active antiretroviral
therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, …

The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time

VD Lima, R Harrigan, DR Bangsberg… - JAIDS Journal of …, 2009 - journals.lww.com
Objective: To characterize the impact of longitudinal adherence on survival in drug-naive
individuals starting currently recommended highly active antiretroviral therapy (HAART) …

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy

VD Lima, RS Hogg, PR Harrigan, D Moore, B Yip… - Aids, 2007 - journals.lww.com
Objective: To characterize the temporal changes in mortality and life expectancy among HIV-positive
individuals initiating antiretroviral therapy in British Columbia, Canada, from 1993 …

The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART

VD Lima, J Geller, DR Bangsberg, TL Patterson… - Aids, 2007 - journals.lww.com
Objective: To determine the impact of depressive symptoms on mortality among HIV/AIDS
patients first initiating HAART and the potential role of patient adherence as a confounder and …

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review …

…, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima… - The Lancet infectious …, 2009 - thelancet.com
Antiretroviral-therapy rollout in resource-poor countries is often associated with limited, if any,
HIV-RNA monitoring. The effect of variable monitoring on the emergence of resistance …

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors …

…, J Li, C Wong, A Willig, VD Lima… - Journal of the …, 2020 - Wiley Online Library
Introduction Weight gain following antiretroviral therapy (ART) initiation is common, potentially
predisposing some persons with HIV (PWH) to cardio‐metabolic disease. We assessed …

The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study

B Nosyk, JSG Montaner, G Colley, VD Lima… - The Lancet infectious …, 2014 - thelancet.com
Background The cascade of HIV care has become a focal point for implementation efforts to
maximise the individual and public health benefits of antiretroviral therapy. We aimed to …